about
Data-driven strategy for the discovery of potential urinary biomarkers of habitual dietary exposure.Postprandial changes in cardiometabolic disease risk in young Chinese men following isocaloric high or low protein diets, stratified by either high or low meal frequency - a randomized controlled crossover trialDietary exposure biomarker-lead discovery based on metabolomics analysis of urine samples.Body Composition in Asians and Caucasians: Comparative Analyses and Influences on Cardiometabolic Outcomes.Vinegar as a functional ingredient to improve postprandial glycemic control-human intervention findings and molecular mechanisms.Profiling of phenols in human fecal water after raspberry supplementation.Hydroxylated phenylacetamides derived from bioactive benzoxazinoids are bioavailable in humans after habitual consumption of whole grain sourdough rye bread.Genetic and phenotypic determinants of flavonoid absorption and metabolism: the COB study.Polyphenol-rich curry made with mixed spices and vegetables benefits glucose homeostasis in Chinese males (Polyspice Study): a dose-response randomized controlled crossover trial.Influence of habitual diet on antioxidant status: a study in a population of vegetarians and omnivores.Metabolomics and human nutrition.Effects of Two Doses of Curry Prepared with Mixed Spices on Postprandial Ghrelin and Subjective Appetite Responses-A Randomized Controlled Crossover Trial.Dose-Dependent Increase in Unconjugated Cinnamic Acid Concentration in Plasma Following Acute Consumption of Polyphenol Rich Curry in the Polyspice StudyPolyphenol-rich curry made with mixed spices and vegetables increases postprandial plasma GLP-1 concentration in a dose-dependent mannerPostprandial Glycemic and Insulinemic Effects of the Addition of Aqueous Extracts of Dried Corn Silk, Cumin Seed Powder or Tamarind Pulp, in Two Forms, Consumed with High Glycemic Index RiceHigh or low glycemic index (GI) meals at dinner results in greater postprandial glycemia compared with breakfast: a randomized controlled trial
P50
Q30583373-86E4DA52-0577-43BF-9920-233651F18590Q36691514-6AC3E71F-A7D8-4957-BAD4-1D389424D26FQ38103088-E03618F2-D7E8-4AF2-9BE6-A7937679A38FQ38576438-9B655227-543A-4907-A1E6-B476DE3632D6Q38841654-AF7791DF-D9E7-4CDF-868E-C244B70C3C42Q42920520-E7806F15-DCC6-4E75-8A0A-D84045AE889BQ44415098-B865D28A-7F2E-49EC-A1CB-5646D5112ADBQ45789280-9C822A51-689C-4F28-9901-59DBAA8DD772Q48125653-A6CE39B0-5AA5-43A5-ACF0-4F24E5D9C0C9Q51478226-C60C47C9-737A-48BE-821C-FC71EDF8C4ACQ51763931-AF62372D-BDBC-4913-A645-9F5184B58C5FQ54943393-5850FEF8-59D0-4334-8894-7923B9F834D4Q58897476-A54C53EF-6730-4231-9FD9-B811F56CD011Q58897495-C0507876-D326-4127-8961-963ED6CFA14CQ90284414-9DC24242-53B6-4370-8B19-F818D69700FEQ93194507-BE75B1D7-F825-4AD5-8FC7-2D5CC0498AE7
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0001-9559-5358
@en
name
Sumanto Haldar
@ast
Sumanto Haldar
@en
Sumanto Haldar
@es
Sumanto Haldar
@nl
type
label
Sumanto Haldar
@ast
Sumanto Haldar
@en
Sumanto Haldar
@es
Sumanto Haldar
@nl
prefLabel
Sumanto Haldar
@ast
Sumanto Haldar
@en
Sumanto Haldar
@es
Sumanto Haldar
@nl
P1053
V-3053-2017
P106
P1153
15841388100
P31
P3829
P496
0000-0001-9559-5358